Select a company

Go

Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted

Sector

  • Energy and Renewables
  • IT & Communications
  • Chemicals & Materials
  • Biotech
  • Healthcare

University

  • University of Bath
  • University of Bristol
  • University of Cardiff
  • University of Glasgow
  • University of Leeds
  • King's College London
  • Queen Mary, University of London
  • University of Manchester
  • University of Nottingham
  • University of Oxford
  • University of Sheffield
  • University of Southampton
  • University of Surrey
  • Swansea University
  • University of York
  • Other

Stakeholder

  • IP Group
  • IP Venture Fund
  • Top 10 Holdings
    by value
Pharma & Biotech

University: Leeds

Company Stage: Quoted

Website: http://www.evocutis.com

Evocutis

As a leading dermatology company, Evocutis provides a comprehensive range of contract research services to support skin science R&D. Whether it’s conducting innovative research, selecting the most effective formulation or supporting a new marketing claim Evocutis can help speed up development programmes. The company has three main areas of specialism:

  • Skin microbiology
  • Living Skin Equivalents
  • Clinical evaluations

As at 31 Dec 2012

IP Group holding

IP Venture Fund* holding

16.7%

7.9%

*IP Group has a 10%
economic interest in IP
Venture Fund

Holdings represent undiluted beneficial equity interest excluding debt

Evocutis

Related news

19 Mar 2014
13 Mar 2014

There is currently no news available.

More portfolio news